Evidence map›Paper›PMID 42477419›Full record

ArticleCommunications biology2026

BubR1 TPR domain supports the mitotic checkpoint by promoting MCC formation and MCC-APC/C interaction.

Mingzhe Zhang, Tingting Lei, Ying Wang, Mingyan Li, Yutong Wang, Jing Fang, Gang Zhang

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingzhe Zhang *Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Tingting Lei *Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Ying WangSchool of Public Health, Qingdao University, Qingdao, China.
Mingyan LiCancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Yutong WangCancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Jing FangCancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Gang ZhangCancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China. zhanggang_sma@qdu.edu.cn.ORCID 0000-0001-7697-7203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BubR1 is a key component of the mitotic checkpoint, a surveillance mechanism which ensures accurate chromosome segregation by facilitating the assembly of the mitotic checkpoint complex (MCC) and promoting its binding to the anaphase-promoting complex/cyclosome (APC/C). Although BubR1's role in the mitotic checkpoint has been extensively investigated, the function of its N-terminal tetratricopeptide repeat (TPR) domain remains poorly understood. In this study, we first establish the essential role of the BubR1 TPR domain in the mitotic checkpoint. Guided by the resolved cryo-EM structure of the MCC-APC/C complex, we identify and characterize several interactions between the BubR1 TPR domain and Mad2, Cdc20

Indexed as

Anaphase-Promoting Complex-CyclosomeM Phase Cell Cycle CheckpointsProtein Serine-Threonine KinasesCdc20 ProteinsCryoelectron MicroscopyHeLa CellsHumansMad2 ProteinsProtein BindingProtein DomainsAnaphase-Promoting Complex-CyclosomeBUB1 protein, humanCDC20 protein, humanCdc20 ProteinsMad2 ProteinsProtein Serine-Threonine Kinases

Identifiers

PMID42477419
PMCPMC13385977

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.